Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States

Edmund J. Bini; Steven Kritz; Lawrence S. Brown; Jim Robinson; Donald Calsyn; Don Alderson; Kathlene Tracy; Patrick McAuliffe; Cheryl Smith; John Rotrosen

doi:10.1016/j.jsat.2011.09.007

Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States

Edmund J. Bini, Steven Kritz, Lawrence S. Brown, Jim Robinson, Donald Calsyn, Don Alderson, Kathlene Tracy, Patrick McAuliffe, Cheryl Smith, John Rotrosen

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This study evaluated the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network. Our survey of substance abuse treatment program administrators covered availability of testing for HBV and HCV; hepatitis A virus (HAV) and HBV immunization; and HCV medical and nonmedical services. There were also questions covering clarity of guidelines for HBV and HCV testing and HAV and HBV immunization. Differences between methadone and nonmethadone programs were examined. Despite the importance of substance abuse in sustaining the hepatitis epidemics, few programs offer comprehensive HBV and HCV testing or HCV health care services. Interventions to improve access to hepatitis services for substance-abusing patients are needed.

Original language	English
Pages (from-to)	438-445
Number of pages	8
Journal	Journal of Substance Abuse Treatment
Volume	42
Issue number	4
DOIs	https://doi.org/10.1016/j.jsat.2011.09.007
State	Published - Jun 2012
Externally published	Yes

Keywords

Hepatitis B virus
Hepatitis C virus
Substance abuse treatment programs

Access to Document

10.1016/j.jsat.2011.09.007

Cite this

@article{fbf790e638ad4bea9e34646b8345e448,

title = "Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States",

abstract = "Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This study evaluated the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network. Our survey of substance abuse treatment program administrators covered availability of testing for HBV and HCV; hepatitis A virus (HAV) and HBV immunization; and HCV medical and nonmedical services. There were also questions covering clarity of guidelines for HBV and HCV testing and HAV and HBV immunization. Differences between methadone and nonmethadone programs were examined. Despite the importance of substance abuse in sustaining the hepatitis epidemics, few programs offer comprehensive HBV and HCV testing or HCV health care services. Interventions to improve access to hepatitis services for substance-abusing patients are needed.",

keywords = "Hepatitis B virus, Hepatitis C virus, Substance abuse treatment programs",

author = "Bini, \{Edmund J.\} and Steven Kritz and Brown, \{Lawrence S.\} and Jim Robinson and Donald Calsyn and Don Alderson and Kathlene Tracy and Patrick McAuliffe and Cheryl Smith and John Rotrosen",

note = "Funding Information: This study was supported by the NIDA/National Institutes of Health via the NIDA CTN ( U10-DA13046 ). We are indebted to the efforts of administrators, clinicians, and investigators of the 17 universities and medical centers along with the participating community-based substance abuse treatment programs of the NIDA CTN.",

year = "2012",

month = jun,

doi = "10.1016/j.jsat.2011.09.007",

language = "English",

volume = "42",

pages = "438--445",

journal = "Journal of Substance Abuse Treatment",

issn = "0740-5472",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States

AU - Bini, Edmund J.

AU - Kritz, Steven

AU - Brown, Lawrence S.

AU - Robinson, Jim

AU - Calsyn, Donald

AU - Alderson, Don

AU - Tracy, Kathlene

AU - McAuliffe, Patrick

AU - Smith, Cheryl

AU - Rotrosen, John

N1 - Funding Information: This study was supported by the NIDA/National Institutes of Health via the NIDA CTN ( U10-DA13046 ). We are indebted to the efforts of administrators, clinicians, and investigators of the 17 universities and medical centers along with the participating community-based substance abuse treatment programs of the NIDA CTN.

PY - 2012/6

Y1 - 2012/6

N2 - Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This study evaluated the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network. Our survey of substance abuse treatment program administrators covered availability of testing for HBV and HCV; hepatitis A virus (HAV) and HBV immunization; and HCV medical and nonmedical services. There were also questions covering clarity of guidelines for HBV and HCV testing and HAV and HBV immunization. Differences between methadone and nonmethadone programs were examined. Despite the importance of substance abuse in sustaining the hepatitis epidemics, few programs offer comprehensive HBV and HCV testing or HCV health care services. Interventions to improve access to hepatitis services for substance-abusing patients are needed.

AB - Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This study evaluated the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network. Our survey of substance abuse treatment program administrators covered availability of testing for HBV and HCV; hepatitis A virus (HAV) and HBV immunization; and HCV medical and nonmedical services. There were also questions covering clarity of guidelines for HBV and HCV testing and HAV and HBV immunization. Differences between methadone and nonmethadone programs were examined. Despite the importance of substance abuse in sustaining the hepatitis epidemics, few programs offer comprehensive HBV and HCV testing or HCV health care services. Interventions to improve access to hepatitis services for substance-abusing patients are needed.

KW - Hepatitis B virus

KW - Hepatitis C virus

KW - Substance abuse treatment programs

UR - https://www.scopus.com/pages/publications/84860385312

U2 - 10.1016/j.jsat.2011.09.007

DO - 10.1016/j.jsat.2011.09.007

M3 - Article

C2 - 22035702

AN - SCOPUS:84860385312

SN - 0740-5472

VL - 42

SP - 438

EP - 445

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

IS - 4

ER -

Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States

Abstract

Keywords

Access to Document

Fingerprint

Cite this